Android app on Google Play

Guggenheim Starts Trius Therapeutics (TSRX) at Buy

May 10, 2013 7:26 AM EDT Send to a Friend
Get Alerts TSRX Hot Sheet
Price: $13.63 --0%

Rating Summary:
    11 Buy, 3 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 14 | Down: 14 | New: 19
Trade TSRX Now!
Join SI Premium – FREE
Guggenheim initiates coverage on Trius Therapeutics (NASDAQ: TSRX) with a Buy. PT $20.00.

For an analyst ratings summary and ratings history on Trius Therapeutics click here. For more ratings news on Trius Therapeutics click here.

Shares of Trius Therapeutics closed at $6.61 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Add Your Comment